Press Releases InVivo Therapeutics Holdings Corp.

Equities

NVIV

US46186M6057

Market Closed - OTC Markets Other stock markets 10:03:31 2024-05-21 am EDT			5-day change	1st Jan Change
0.3853 ^USD	-1.20%		+1.39%	-47.22%

Apr. 16	North American Morning Briefing : Powell Comments, -2-	DJ
Apr. 02	North American Morning Briefing : Stocks Seen -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InVivo Therapeutics : Shareholder Meeting - Form 8-K	Nov. 30	PU
InVivo: Q3 Earnings Snapshot	Nov. 09	AQ
InVivo Therapeutics : Termination of Material Agreement - Form 8-K	23-09-01	PU
INVIVO THERAPEUTICS HOLDINGS CORP. : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-09	AQ
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury	23-03-09	BU
INVIVO THERAPEUTICS HOLDINGS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-01	AQ
INVIVO THERAPEUTICS HOLDINGS CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-11-18	AQ
InVivo: Q3 Earnings Snapshot	22-11-08	AQ
INVIVO THERAPEUTICS HOLDINGS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	22-11-07	AQ
INVIVO THERAPEUTICS HOLDINGS CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-10-11	AQ
InVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules	22-10-11	BU
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market under Nasdaq Rules	22-10-10	AQ
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules	22-10-07	BU
InVivo Therapeutics : Modification to Rights of Security Holders - Form 8-K	22-09-13	PU
INVIVO THERAPEUTICS HOLDINGS CORP. : Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	22-09-13	AQ
InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference	22-09-12	AQ
InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference	22-09-09	BU
INVIVO THERAPEUTICS HOLDINGS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	22-08-08	AQ
InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel	22-07-13	BU
INVIVO THERAPEUTICS HOLDINGS CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-07-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases InVivo Therapeutics Holdings Corp.

Equities

NVIV

US46186M6057

Press Releases

Filters